³Ô¹ÏÍøÕ¾

Latest rare diseases News

Establishing Genomics Australia
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
One gene provides diagnoses for 30 patients whose condition was unexplained for years
MMK researchers receives funding from the Swedish Cancer Society
Albanese Government indefinitely DEFERS patient access to 44 medicines on PBS
Complex Diagnoses Can Be Solved With New Technology
Adelaide family the key to new disease breakthrough
Genomics program designed for diverse communities starts recruiting
Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
Cutting corners results in rare genetic diseases being undiagnosed, say scientists
Insights To Innovation: Bridging Funding Gap
UN expert calls for systematic monitoring and assessment of adverse human rights impact of unilateral coercive measures
$71 million for clinical trials and research into the best multidisciplinary models of primary care
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Prize-winning images showcase the beauty of medical research
Neurodegenerative, Palliative Care and Rare Diseases Advisory Group May 2024 communique
Mutated bone stem cells caught in a loop leading to osteogenesis imperfecta type V
Power Of Patient Experience In Rare Ovarian Cancer
Pan American Health Organization regional meeting on human genomic research for health held
When there’s no commercial incentive to develop gene therapy – hospitals will try to fill the gap
No commercial incentive to develop gene therapy – hospitals will try to fill the gap
WHO joins partners at ASEAN regional meeting to boost access to quality diagnostic testing
UQ researcher investigates revolutionary treatment for rare brain cancer
Dimerix announces Middle East license agreement for DMX-200
ACTION Centre to boost access to life-saving new therapies for children
Tracking Down Rare Hereditary Diseases
First expert meeting to accelerate access to human genomics in the WHO Western Pacific Region convened in Manila
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
KI strengthens collaboration with pharmaceutical company Chiesi
Using AI To Improve Diagnosis Of Rare Genetic Disorders
³Ô¹ÏÍøÕ¾ Centre To Tackle Rare Lung Diseases
Curious Kids: how is eye colour made? And why are they different colours?
More rare conditions considered for newborn bloodspot screening and new treatment option for spinal muscular atrophy
Losing their tails provided our ape ancestors with an evolutionary advantage – but we’re still paying the price
Acquisition Of Gracell Completed
Acquisition of Icosavax Completed
Tagrisso demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial
Game changing gene therapies focus of £14m research hub
New Cellular Lab To Back Victorian Blood Cancer Research
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
Research aims to transform haemophilia treatment
Centenary researchers awarded more than $2m in Ideas Grants
Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune
Neurodegeneration in myelin disease: no myelin is better than bad myelin
Unlocking power of genomics with $66 million for research
Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
$147.5 million for research into rare illnesses, multidisciplinary primary care, cardiovascular disease and diabetes